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Experimental hookworm infection 
and escalating gluten challenges 
are associated with increased 
microbial richness in celiac subjects
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Leisa McCann3, Severine Navarro1, Makedonka Mitreva5,6, Lutz Krause2,7,  
Alex Loukas1,* & Cinzia Cantacessi1,4,*
The intestinal microbiota plays a critical role in the development of the immune system. Recent 
investigations have highlighted the potential of helminth therapy for treating a range of 
inflammatory disorders, including celiac disease (CeD); however, the mechanisms by which helminths 
modulate the immune response of the human host and ameliorate CeD pathology are unknown. In 
this study, we investigated the potential role of alterations in the human gut microbiota in helminth-
mediated suppression of an inflammatory disease. We assessed the qualitative and quantitative 
changes in the microbiota of human volunteers with CeD prior to and following infection with human 
hookworms, and following challenge with escalating doses of dietary gluten. Experimental hookworm 
infection of the trial subjects resulted in maintenance of the composition of the intestinal flora, 
even after a moderate gluten challenge. Notably, we observed a significant increase in microbial 
species richness over the course of the trial, which could represent a potential mechanism by which 
hookworms can regulate gluten-induced inflammation and maintain intestinal immune homeostasis.
The human gut is inhabited by ~1000 species of bacteria (i.e. the gut microbiota) that play essential roles 
in human health, including nutrient metabolism, protection against pathogens and regulation of both 
innate and adaptive immune responses1-3. The nature and composition of the intestinal microbiota is 
subject to a range of factors, including host genetics, immune status, diet and co-infections with extra-
neous pathogens4. Perturbations in the symbiotic relationship that exists between the commensal micro-
biota and the host immune system have been associated with a number of chronic inflammatory and 
metabolic diseases of the gastrointestinal tract, including obesity, diabetes, inflammatory bowel disease 
(IBD) and celiac disease (CeD), disorders that are becoming increasingly prevalent, particularly in the 
developed world5-7. For example, both the concentrations of mucosally-associated bacteria and the nature 
of the bacterial species are distinct in individuals with IBD, with substantial depletions in Bacteroidetes 
and Lachnospiraceae and expansion of populations of Actinobacteria and Proteobacteria8,9. Similarly, 
CeD (an autoimmune disorder characterised by an inappropriate immune response to dietary gluten) 
is associated with increased populations of Bifidobacterium spp. and Staphylococcus spp. and reductions 
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in Bacteroides spp.10. Hence, addressing the microbiological alterations in patients with these chronic 
inflammatory disorders may be a viable therapeutic strategy, with some encouraging findings from a 
limited number of small studies11-13.
One of the hypotheses as to why allergic and autoimmune diseases of the gastrointestinal tract, such 
as food allergy and CeD, are increasing is the change in relative exposure to commensal and pathogenic 
organisms as a consequence of urbanization and improved sanitation in the developed world14. It has 
been proposed that re-introduction of some of these infectious organisms, and particularly of parasitic 
helminths, could lead to novel therapies to treat autoimmune diseases15-22. One of the mechanisms by 
which helminths have been proposed to regulate immune homeostasis is via modulation of bacterial 
communities in the intestine23-25. However, these studies were performed in animal models of helminth 
infection and it is unclear if similar mechanisms operate in humans.
We have recently demonstrated that experimental infection with the human hookworm, Necator 
americanus, improved gluten tolerance in CeD subjects22. N. americanus infections were associated with 
suppression of pro-inflammatory cytokines and increase of both the frequency of immune-regulatory 
cells and cytokines in the gut following gluten challenges19,22,26; however, the mechanism/s by which 
hookworms modulate the immune response of their human hosts, thus potentially ameliorating the 
symptoms of chronic inflammatory disorders of the intestinal tract, are yet to be fully understood. In 
particular, given the role played by gut dysbiosis in the pathogenesis of CeD27, it is possible that the 
‘curative’ properties of hookworms are partly associated with the ability of these parasites to induce 
qualitative and/or quantitative modifications in the gut microbiota, thus contributing to the restora-
tion of intestinal immune homeostasis. To address this hypothesis, we recently investigated the impact 
that experimental infections of healthy CeD subjects (on a gluten-free diet, GFD) with N. americanus 
exert on the composition of the gut microbiota and the relative abundance of different microbial spe-
cies28. No detectable qualitative and quantitative differences were observed between samples prior to and 
8 weeks following hookworm infection, thus indicating that the microbial community composition of 
each subject remained stable over the relatively short timeframe of the study28. However, the changes in 
gut microbiota of hookworm-infected CeD subjects following gluten challenge was not investigated. In 
the present study, capitalising on the sampling opportunities provided by our published clinical trial22, 
we explore the qualitative and quantitative changes in gut microbiota of CeD subjects prior to and fol-
lowing experimental infection with N. americanus, as well as following the administration of escalating 
doses of gluten.
Results
The fecal microbiota of Trial subjects differs from that of active CeD control subjects. Each 
of the eight Trial subjects had been on a strict GFD for at least 5 years prior to trial commencement, and 
recorded sub-clinical Marsh scores prior to entering the trial22. We first assessed the baseline pre-trial 
(T0) composition of the fecal microbiota of the Trial subjects and compared it with that of a cohort of 
individuals from the same metropolitan area with active Marsh 3 + grade CeD (Table S1). Trial sub-
jects displayed a greater abundance of the phylum Bacteroidetes than Control subjects (t-test: p = 0.04; 
FDR = 0.12), while Firmicutes were more abundant in the Control subjects (p = 0.07; FDR = 0.12, 
Figs 1A and 2). In addition, Tenericutes RF39 were detected in the fecal microbiota of all Control sub-
jects, but only in one Trial subject (ID12; Fig. 2). At the class level, Bacteroidia were more prevalent in 
the Trial subjects (p = 0.04; FDR = 0.17), whereas Erysipelotrichi were more abundant in the Control 
subjects (p = 0.02; FDR = 0.17), as were Clostridia, although the differences did not reach significance 
(p = 0.13; FDR = 0.2, Fig. 1B). Similarly, at genus level, Ruminococcus dominated the fecal microbiota of 
the Control subjects (p = 0.001; FDR = 0.02, Fig. 1C), while Lachnospira was more abundant in the Trial 
subjects (p = 0.027; FDR = 0.16) (Fig. 1C). Comparison of Kyoto Encyclopedia of Genes and Genomes 
(KEGG) functional profiles (predicted by PICRUSt) of Trial subjects pre-trial with those of the Control 
subjects displayed differential regulation of 8 biological pathways, with up-regulation of pathways linked 
to sugar uptake (i.e. “Multiple sugar transport system permease protein”, KO codes K02026 and K02025; 
p < 0.03; FDR = 0.2) in the Control subjects (Figure S1), associated with bacteria within the genus 
Ruminococcus (data not shown). Together, these data demonstrated that the microbiota of the healthy 
Trial subjects pre-hookworm and pre-gluten challenge was distinct from individuals with active CeD.
Changes in fecal microbiota following hookworm infection and gluten challenge revealed by 
targeted gene sequencing. We next aimed to assess whether the nature of the commensal makeup 
was altered in the Trial subjects following experimental hookworm infection and subsequent escalating 
gluten challenges. All eight subjects were successfully infected with N. americanus, as evidenced by pos-
itive detection of hookworm eggs in the feces from weeks 8 to 52 post-infection22. Fecal samples were 
collected from each of these subjects 8 weeks after hookworm infection (T8), as well as at defined inter-
vals following sequential challenges with 50 mg gluten/day for 12 weeks (T24), 350 mg gluten/day for 12 
weeks (T36) and 3 g gluten/day for 2 weeks (T52). All samples were subjected to 454-based metagenomic 
sequencing; however, two Trial subjects did not provide fecal samples at either T52 (subject ID2) or 
T36 and T52 (ID12), hence sequence data was not available for these individuals at these time points. 
In addition, as the raw sequence data for Trial subject ID10 at T36 consisted of a total of 18 sequences 
only, this sample was excluded from subsequent analyses. A total of 346,669 useable reads were assigned 
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to 7,262 Operational Taxonomic Units (OTUs) and 6 bacterial phyla, respectively (data available from 
the corresponding author upon request). Consistent with previous investigations, including our own28, 
the phyla Bacteroidetes and Firmicutes dominated the intestinal microbiota of all subjects included in the 
Figure 1. The fecal microbiota of Trial subjects differs from that of active CeD control subjects. 
Differences in the composition of the fecal microbiota of Trial subjects prior to hookworm infection (T0) 
and of active celiac disease Control subjects were determined at (A) phylum, (B) class and (C) genus level.  
*p < 0.05, **p < 0.01.
Figure 2. Composition of the fecal microbial communities (at phylum level). Microbial composition 
of fecal samples from Trial subjects (ID*) prior to and following infection by Necator americanus (T0 and 
T8, respectively), as well as following administration of escalating doses of gluten (50 mg/day – T24;  
350 mg/day – T36; 3 g/day – T52) as predicted in the analysis of the V1-V3 16S rRNA gene. The 
composition of the microbial communities detected in fecal samples from Control subjects with active 
celiac disease (C*) is also shown.
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study at all time points investigated (Figs 2 and 3), with substantial inter-individual differences observed 
at all time points with regard to some of the less abundant phyla such as Proteobacteria, Tenericutes 
and Verrucomicrobia (Fig. 2). Further analysis of specific OTUs within the major phyla of Bacteroidetes 
and Firmicutes again revealed substantial inter-individual variation at all time points examined (Fig. 3).
Hookworm infection and gluten challenge is associated with increased microbial richness. 
Consistent with the results of our previous study28, a Principal Coordinates Analysis (PCoA) of the 
fecal microbial communities detected in the Trial subjects showed strong clustering of the samples by 
individual rather than infection status and/or exposure to escalating doses of gluten in the two main 
dimensions (Fig.  4), thus indicating that the community composition of each subject remained stable 
over the course of the trial. Similarly, both Anosim and Redundancy Analysis (RDA) indicated a clear 
clustering of samples by individual (p = 0.001 Anosim; p < 0.001 RDA). In the Trial subjects, hookworm 
infection and/or exposure to escalating doses of gluten did not impact community structure (p > 0.1 
Figure 3. Composition of the fecal microbial communities at phylotype level. Microbial composition 
of fecal samples from Trial subjects (ID*) prior to and following infection by Necator americanus (T0 
and T8, respectively), as well as following administration of escalating doses of gluten (50 mg/day – T24; 
350 mg/day – T36; 3 g/day – T52) as predicted in the analysis of the V1-V3 16S rRNA gene. Bubble sizes 
reveal the relative abundance (%) of phylotypes (based on 97% sequence identity) in each sample. The 
composition of the microbial communities detected in fecal samples from Control subjects with active celiac 
disease (C*) is also shown. OTUs listed were present in at least one sample at a relative abundance of ≥ 7%.
Figure 4. Principal coordinates analysis (PCoA) reveals stable composition of fecal microbial 
communities over time. The fecal microbiota of Trial subjects prior to and following experimental infection 
with Necator americanus, and following administration of escalating doses of gluten was assessed by PCoA. 
The composition of the microbial communities detected in fecal samples from Control subjects with active 
celiac disease is also shown. Community similarity was calculated using the Jaccard distance measure of the 
phylotypes.
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Anosim, p > 0.16 RDA), which is indicative of an inter-individual variability and intra-individual stabil-
ity of the gut microbiota despite hookworm infection and gluten challenge. In line with this observation, 
there was no significant difference in relative abundance of any individual OTU identified in the study 
(97% sequence identity) across time points (FDR > 0.54 with both t-test and Wilcoxon test). While no 
significant difference in Shannon diversity was observed on the global microbial communities over the 
whole course of the study (p = 0.91, ANOVA), we detected a significant increase in bacterial species 
richness at T52 (following hookworm infection and exposure to 3 g/day of gluten) when compared to 
T0 (prior to hookworm infection) (p = 0.033, paired t-test) and at T36 (following hookworm infection 
and exposure to 350 mg/day gluten) when compared to T8 (following hookworm infection but prior to 
gluten challenge) (Fig.  5) (p = 0.007). Together, these data suggest that hookworm infection supports 
maintenance of the composition of the intestinal flora in the presence of escalating gluten challenges, 
with concomitant significant increases in microbial species richness.
Discussion
In our recent study22, we showed that experimental infections with N. americanus enabled individuals 
with CeD to tolerate escalating challenges with dietary gluten. The biological, immunological and molec-
ular mechanisms underlying this outcome are yet to be fully determined; however, we hypothesized 
that an expansion of regulatory T cells, together with reductions in pro-inflammatory effector T cells in 
the duodenum, may have been responsible for the restoration of the intestinal homeostasis and, conse-
quently, for the improved gluten tolerance19,22,26. However, other elements within the complex spectrum 
of host-parasite interactions may have contributed to this cascade of biological events in the study sub-
jects. Here, we evaluated the impact of hookworm infection and gradual re-introduction of gluten into 
the diet on the microbial communities inhabiting the intestine of the same cohort of volunteers who 
took part in the clinical study22.
We had hypothesized that experimental hookworm infection, combined with exposure to escalating 
doses of gluten, would result in significant quantitative and qualitative fluctuations of the gut microbiota 
populations of the volunteers. However, we detected no significant differences in the overall community 
structure, Shannon diversity or relative abundance of individual bacterial species over the course of our 
study, in accordance with the findings of our previous investigation in which a 8-week, acute hookworm 
infection alone did not result in significant alterations of the fecal microbiota28. However, in the present 
study, we observed a significantly increased microbial richness (= total number of microbial species pres-
ent) in fecal samples of Trial subjects collected following hookworm infection and moderate gluten chal-
lenge, compared with pre-trial samples. One possible explanation for this discrepancy is that hookworms 
may actively contribute to the maintenance of bacterial homeostasis in the gut28 and ‘restore’ homeostasis 
(by promoting an increase in microbial richness) when inflammatory responses are triggered (e.g. by the 
introduction of gluten in a celiac subject). Alternatively, it is possible that hookworm-induced changes 
in microbial species richness can only be detected following the establishment of chronic, rather than 
acute, infections28. The latter theory is also substantiated by the results of a recent investigation, in which 
a significantly increased species richness was detected in the intestinal microbiota of individuals from 
indigenous Malaysian communities naturally infected with gastrointestinal helminths (Trichuris and/or 
Figure 5. Hookworm infection and gluten challenge is associated with increased microbial richness. 
Pairwise comparisons depicting the overall taxonomic richness of the fecal microbiota of Trial subjects (A) 
prior to hookworm infection (T0) and following the administration of escalating doses of gluten (T52), and 
(B) post-hookworm infection (T8) and post-gluten challenge (T52), respectively.
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hookworms and/or Ascaris sp.) when compared with helminth-free, uninfected subjects from the same 
areas29. Similarly, a study using a primate model of chronic idiopathic diarrhea showed that experimental 
infections with whipworms were associated with a significant increase of microbial species richness and 
evenness (= diversity) which, in turn, had been hypothesized to play a role in the restoration of intestinal 
homeostasis and symptomatic improvement24. In our study, the increase in species richness that followed 
hookworm infection was not associated with an increase in Shannon diversity (p > 0.05). This finding 
may be the result of limited statistical power as direct consequence of our small sample size, which may 
also have been responsible for the small (albeit significant) differences in microbial species richness 
observed over the course of the study. Nevertheless, a higher species richness of the gut microbiota has 
generally been associated with a “healthier” intestinal homeostasis30-32. In particular, a study comparing 
the intestinal microbiota of subjects suffering from Crohn’s Disease and Ulcerative Colitis with that of 
healthy controls revealed that species richness was significantly higher in the latter30. In addition, the 
microbiota isolated from non-inflamed tissue from diseased subjects displayed significantly increased 
species richness when compared with that from inflamed biopsy samples from the same individuals30. 
Therefore, based on the results of the present and previous studies that associate increased microbial 
species richness to infections with helminths29 and the amelioration of inflammation24,30-32, we hypoth-
esize that the therapeutic properties of hookworms may be partly linked to their ability to promote 
species richness and restore/maintain microbial (and immune) homeostasis in the gastrointestinal tract28. 
However, one limitation of our clinical study22 was the unavailability of a hookworm- or gluten-placebo 
cohort; therefore, larger placebo-controlled trials, together with the definition of the enterotype of each 
subject33, are necessary to confirm whether hookworms alone, or the gradual reintroduction of dietary 
gluten, are involved in modulation of the microbiota.
Three fecal samples from volunteers with active CeD (Control) were included in our study and com-
pared with the pre-trial (T0) samples from the Trial subjects. Quantitative differences in the abundance 
of the main phyla were observed between the two groups; in particular, the Firmicutes dominated the 
microbiota of the Control subjects with active CeD (albeit this difference was below statistical signifi-
cance), whereas the Bacteroidetes were more abundant in the healthy Trial subjects. Despite this overall 
trend, the genus Lachnospira (a Firmicutes) was more abundant in the Trial subjects (but below statis-
tical significance); Clostridia and Ruminococcus (both within the phylum Firmicutes) dominated the 
fecal microbiota of the Control subjects. A shift in the Bacteroidetes to Firmicutes ratio in association 
with active CeD has already been documented in a previous study examining the effects of sustained 
GFD on the composition of the duodenal microbiota of adult CeD volunteers6,13. Given the recently 
described roles of Firmicutes in the metabolism of gluten34, the abundance of bacteria within this phylum 
in subjects with active CeD may reflect the dietary habits of these volunteers. In contrast, the abun-
dance of Clostridia and Ruminococcus (at the class and genus level, respectively), in the Control subjects 
is in disagreement with previous findings reporting Methylobacterium (class Alphaproteobacteria) and 
Mycobacterium (Actinobacteria) as the prevalent genera of bacteria in the gut microbiota of adults with 
active CeD6. One possible explanation for this discrepancy is technical, and likely to be associated to 
methodological differences between our study and that by Nistal et al.6; indeed, the latter utilized PCR 
amplification of the bacterial 16 S rRNA gene, followed by cloning and sequencing of randomly-picked 
clones, yielding ~50 sequences per sample. Therefore, in our opinion, the vast difference in sequencing 
depth between our study and that by Nistal et al.6 does not warrant direct comparisons of findings. 
However, a higher prevalence of Clostridia had been detected in the feces of CeD children with active 
disease compared with CeD controls on a strict GFD35. In addition, a recent investigation of the fecal 
microbiota of infants at either high- or low- genetic risk of developing CeD (HLA-DQ2 carriers and 
non-HLA-DQ2 carriers, respectively) revealed that the former is characterized by significantly higher 
proportions of Clostridia27. However, the role of this bacterial group in the progression of CeD is yet to 
be ascertained.
In conclusion, the present study has revealed a potential beneficial consequence of hookworm infec-
tion in the context of an autoimmune disease, i.e. supporting the maintenance and diversity of commen-
sal flora. Whether hookworm-mediated changes in the microbiota are causal for the improved gluten 
tolerance and reduced inflammation in CeD is unknown, but could be examined in greater detail in 
an animal model of the disease. It also remains possible that hookworm-induced immunoregulation is 
mediated by additional mechanisms, in particular the direct actions of parasite excretory/secretory pro-
teins on immune cells36. Clearly, helminth-based therapies hold promise for a range of autoimmune or 
inflammatory conditions, and reversal of the dysbiosis associated with these disorders by tissue-resident 
parasites is one potential mechanism that requires further investigation.
Methods
Ethics statement. This study was approved and carried out in strict accordance and compliance with 
the National Statement on Ethical Conduct in Research Involving Humans guidelines of the National 
Health and Medical Research Council of Australia (NHMRC). The Prince Charles Hospital (Brisbane, 
Australia) and James Cook University Human Research Ethics Committees approved the study. Written 
informed consent was obtained from all subjects enrolled in the study. This study was registered as a 
clinical trial at ClinicalTrials.gov as NCT0067113822.
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Trial design. Eight otherwise healthy volunteers with HLA-DQ2 + or HLA-DQ8 + CeD on a strict 
GFD (> 5 years) (= Trial subjects) were infected percutaneously with 20 infective third stage larvae of 
N. americanus26. Subjects then underwent escalating exposure to dietary gluten (as spaghetti), with a 
10–50 mg/day micro-challenge from weeks 12–24, followed by intermittent twice weekly 1 g/day gluten 
challenge from weeks 24–36 and a 3 g/day challenge from weeks 48–5022. Prior to experimental infection 
(T0), as well as at 8 weeks (T8), 24 weeks (T24), 36 weeks (T36) and 52 weeks (T52) post-infection, indi-
vidual fecal samples were collected from each subject and stored at –20 °C. In addition, individual fecal 
samples from three hookworm-naïve volunteers with active CeD (diagnosed as Marsh grade 3 at the time 
of biopsy22) (= Control subjects) were also included for comparative purposes (Table S1).
DNA extraction and 16S rRNA pyrosequencing. Genomic DNA was extracted directly from 
each sample using the PowerSoilTM DNA isolation kit (MoBio, USA), according to the manufacturer’s 
instructions. The V1-V3 hypervariable region of the 16S gene was PCR amplified using universal primers 
described previously28 and sequenced on a 454 GS-FLX Titanium platform (Roche). Forward primers 
incorporated GS Titanium adapters as well as a sample-specific barcode sequences. Raw sequence data 
have been deposited in the NCBI Sequence Read Archive under accession number SRP059769.
Bioinformatics analyses. Sequence data were processed using the Quantitative Insights Into Microbial 
Ecology (QIIME) software suite37. Briefly, after filtering of low-quality reads, all remaining sequences were 
de-multiplexed, and chimeric sequences were removed using UCHIME v 3.0.617. Sequences were sub-
sequently clustered into Operational Taxonomic Units (OTUs) on the basis of similarity to known bac-
terial sequences in the Greengenes database (v13.5; http://greengenes.secondgenome.com/; cut-off: 97% 
sequence similarity) using the UCLUST software; then, sequences were assigned to taxonomy using the 
Ribosomal Database Project (RDP) Classifier with the confidence level set at 0.8. Statistical analyses and 
data mining were conducted using the Calypso software (http://bioinfo.qimr.edu.au/calypso/). Shannon 
diversity and rarefied richness (rarefy function in vegan Bioconductor package) were compared by paired 
t-test and rarefaction curves. Differences in abundance of individual OTUs were assessed by paired t-test 
on square root transformed relative abundance values and Wilcoxon test (Table S2), and p-values were 
corrected for multiple testing by false discovery rate (FDR). Anosim (Jaccard distance), redundancy anal-
ysis (RDA; including human subject and week as explanatory variables), Principal Coordinates Analysis 
(PCoA; Jaccard distance) and rarefaction analyses were run in Calypso with default parameters. Anosim 
and RDA were applied on the OTU table using Jaccard distance. RDA was executed including the envi-
ronment variables infection status and subject ID. Anosim was run separately for infection status and 
subject ID. The software PICRUSt38 was then used to predict metagenomic functional content from the 
Greengenes-picked OTUs and predict KEGG pathway abundance. Briefly, sequences were clustered into 
OTUs using the reference database Greengenes (v13.5). Reference OTUs were normalized by copy num-
ber, and PICRUSt metagenome predictions were calculated.
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